SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Morales Robert
(Last) (First) (Middle)
420 SAW MILL RIVER ROAD
(Street)
ARDSLEY NY 10502
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/13/2021 		3. Issuer Name and Ticker or Trading Symbol
ACORDA THERAPEUTICS INC [ ACOR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Interim PAO & PFO
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 4,872(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (2) 12/01/2024 Common Stock 1,667 212.88 D
Employee Stock Option (right to buy) (3) 03/04/2025 Common Stock 35 214.44 D
Employee Stock Option (right to buy) (4) 03/02/2026 Common Stock 200 213.18 D
Employee Stock Option (right to buy) (5) 03/01/2027 Common Stock 185 164.85 D
Employee Stock Option (right to buy) (6) 04/24/2027 Common Stock 642 96 D
Employee Stock Option (right to buy) (7) 02/02/2028 Common Stock 334 151.8 D
Employee Stock Option (right to buy) (5) 03/01/2028 Common Stock 284 146.1 D
Employee Stock Option (right to buy) (8) 08/01/2028 Common Stock 334 148.5 D
Employee Stock Option (right to buy) (9) 03/08/2029 Common Stock 395 81.06 D
Employee Stock Option (right to buy) (10) 11/07/2029 Common Stock 2,584 14.46 D
Employee Stock Option (right to buy) (11) 02/16/2030 Common Stock 834 10.74 D
Explanation of Responses:
1. Includes 118 unvested restricted stock awards and 3,300 unvested restricted stock unit awards issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. 59 of the restricted stock awards vest on December 1, 2021 and 59 vest on December 1, 2022, subject to continued service. The restricted stock units each represent a contingent right to one share of the Issuer's common stock, subject to continued service, vesting in installments of 40%, 20%, and 40% at 6 months, 12 months, and 18 months, respectively, after the grant date.
2. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on December 1, 2018.
3. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2019.
4. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2020.
5. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2021.
6. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested based on achievement of specified performance milestones and were fully vested on April 2, 2018.
7. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on February 2, 2018, with the first quarterly installment vesting on May 2, 2018.
8. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on August 1, 2018, with the first quarterly installment vesting on November 1, 2018.
9. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2019, with the first quarterly installment vesting on April 1, 2019.
10. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on November 7, 2019, with the first quarterly installment vesting on February 7, 2020.
11. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on February 16, 2020, with the first quarterly installment vesting on May 16, 2020.
Remarks:
/s/ Robert Morales 03/22/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.